Regulatory Insights | Federal Guidance Related To COVID-19, Volume 3

Food and Drug Administration (FDA) Guidance

April 9, 2020

As the spread of COVID-19 has placed pressure on healthcare resources, the FDA has issued an unprecedented amount of new guidance to give greater flexibility and relief to all parts of the healthcare system so as to better respond for the duration of the national emergency. HIDA has compiled recent guidance from the FDA on PPE, diagnostics and therapeutics.

Download FDA Guidance►
(Adobe PDF File)